title: Feeding experiments of pyridoxine derivatives as vitamin B6.
abstract: In order to compare the nutritional effect of vitamin B6 derivatives, long-term feeding experiments with rats were carried out using pyridoxine-alpha-D-glucoside (PN-alpha-Glc), pyridoxine-beta-D-glucoside (PN-beta-Glc) or epsilon- (N-phosphopyridoxyl)lysine (PNP-Lys) with test diets consisting of basically the AIN-76 composition, except for the addition of 0.1 mg pyridoxine equivalent (PN eq.)/100 g diet. During 21 days of pair-feeding against the vitamin B6-deficient diet group, body weight gain, urinary excretion of xanthurenic acid and pyridoxic acid were measured. After the feeding experiment, rats were killed and examined in terms of liver kynureninase activity (EC 3.7.1.3) with and without adding exogenous pyridoxal 5'-phosphate (PLP), erythrocyte aspartate aminotransferase activity (EC 2.6.1.1), as well as PLP concentration in blood. Rats fed with PN-alpha-Glc grew well, relative to the PN group. On the contrary, PN-beta-Glc poorly served as vitamin B6 source, because average bioavailability was only about 22% in comparison to that of PN (100%). From this long-term feeding experiments, we have shown that PN-alpha-Glc (average bioavailability about 84%) is a good source of vitamin B6 similar to PN.
authors.affiliation: Department of Food Science, Faculty of Agriculture, Gifu University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Maeno
authors.forename: Y
authors.initials: Y
authors.lastname: Morimoto
authors.forename: T
authors.initials: T
authors.lastname: Hayakawa
authors.forename: Y
authors.initials: Y
authors.lastname: Suzuki
authors.forename: H
authors.initials: H
authors.lastname: Tsuge
mesh_terms: D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001682:Biological Availability; D004032:Diet; D004912:Erythrocytes / Q000201:enzymology; D005960:Glucosides / Q000008:administration & dosage; D006867:Hydrolases / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008239:Lysine / Q000008:administration & dosage / Q000031:analogs & derivatives; D008297:Male; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D011735:Pyridoxic Acid / Q000652:urine; D011736:Pyridoxine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D051381:Rats; D017208:Rats, Wistar; D026681:Vitamin B 6 Deficiency; D015430:Weight Gain; D014977:Xanthurenates / Q000652:urine
chemical_list: D005960:Glucosides; D014977:Xanthurenates; C022945:5'-O-(glucopyranosyl)pyridoxine; C028330:xanthurenic acid; D011735:Pyridoxic Acid; D011732:Pyridoxal Phosphate; D001219:Aspartate Aminotransferases; D006867:Hydrolases; C021480:kynureninase; D008239:Lysine; D011736:Pyridoxine